×
About 116,794 results

ALLMedicine™ Multiple Sclerosis Center

Research & Reviews  53,975 results

Drugs for multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pubmed/33976089
The Medical Letter on Drugs and Therapeutics;

May 12th, 2021 - Drugs for multiple sclerosis.|2021||

Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary c...
https://doi.org/10.1177/13524585211012227
Multiple Sclerosis (Houndmills, Basingstoke, England); Pfeuffer S, Rolfes L et. al.

May 12th, 2021 - Oral cladribine has been approved for the treatment of relapsing multiple sclerosis (MS) yet real-world evidence regarding its effectiveness and safety remains scarce. To evaluate efficacy and safety outcomes of MS patients following induction of ...

see more →

Guidelines  109 results

Serum neurofilament light as a biomarker in progressive multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7538221
Neurology Kapoor R, Smith KE et. al.

Jul 17th, 2020 - There is an unmet need in multiple sclerosis (MS) therapy for treatments to stop progressive disability. The development of treatments may be accelerated if novel biomarkers are developed to overcome the limitations of traditional imaging outcomes...

Practical Sleep Information for People With Multiple Sclerosis.
https://doi.org/10.1016/j.apmr.2020.03.009
Archives of Physical Medicine and Rehabilitation; Siengsukon C, Karahan AY et. al.

May 13th, 2020 - Practical Sleep Information for People With Multiple Sclerosis.|2020|Siengsukon C,Karahan AY,Strober L,|

Immediate and Sustained Effects of Interventions for Changing Physical Activity in People with Multiple Sclerosis: Meta-Analysis of Randomized Controlled Trials
https://www.archives-pmr.org/article/S0003-9993(20)30217-3/pdf
Archives of Physical Medicine & Rehibilitation; Kim Y

Apr 24th, 2020 - To examine the immediate and sustained effects of interventions for changing physical activity behavior in people with multiple sclerosis (MS), and explore factors that might moderate intervention effects on physical activity behavior (e.g., inter...

Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162735/
Neurol Sci.; Bonavita S

Apr 16th, 2020 - We propose a possible approach for the remote monitoring of infection risk in people with multiple sclerosis, especially those on immunosuppressant drugs, during COVID-19 pandemic. We developed a digital triage tool to be sent to patients to quick...

MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063292/
Quantitative Imaging in Medicine and Surgery; Barnett Y,et al

Feb 27th, 2020 - Over more than 35 years, advances in magnetic resonance imaging (MRI) techniques and analysis have fundamentally impacted both diagnostic criteria and treatment algorithms for multiple sclerosis (MS), a potentially disabling neurologic condition t...

see more →

Drugs  395 results see all →

Clinicaltrials.gov  57,219 results

Drugs for multiple sclerosis.
https://www.ncbi.nlm.nih.gov/pubmed/33976089
The Medical Letter on Drugs and Therapeutics;

May 12th, 2021 - Drugs for multiple sclerosis.|2021||

Effectiveness and safety of cladribine in MS: Real-world experience from two tertiary c...
https://doi.org/10.1177/13524585211012227
Multiple Sclerosis (Houndmills, Basingstoke, England); Pfeuffer S, Rolfes L et. al.

May 12th, 2021 - Oral cladribine has been approved for the treatment of relapsing multiple sclerosis (MS) yet real-world evidence regarding its effectiveness and safety remains scarce. To evaluate efficacy and safety outcomes of MS patients following induction of ...

see more →

News  4,973 results

Some MS Treatments May Heighten COVID Risk
https://www.medscape.com/viewarticle/950166

Apr 28th, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. When it comes to SARS-CoV-2 infection among patients with multiple sclerosis (MS), disease-modifying therapies (DMTs) seem to have varying effects...

Investigational Drug Reduces Brain Lesions in Highly Active MS
https://www.medscape.com/viewarticle/949966

Apr 25th, 2021 - The investigational drug tolebrutinib effectively reduces brain lesions in patients with highly active relapsing-remitting multiple sclerosis (RRMS), new research suggests. After 12 weeks of treatment, MRI revealed the drug, a Bruton's tyrosine ki...

MRI Before Pregnancy Predicts Early Postpartum MS Relapse
https://www.medscape.com/viewarticle/949524

Apr 18th, 2021 - For women with multiple sclerosis (MS), results of MRI performed during the year before they become pregnant appear to accurately predict early relapse after childbirth, new research shows. Investigators found that women for whom there was evidenc...

Common MS Treatment Wears Off More Quickly in Black Patients
https://www.medscape.com/viewarticle/949488

Apr 16th, 2021 - Black patients with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder (NMOSD) may respond differently to common MS treatment compared to their White peers, new research suggests. In a study of almost 200 patients, Black participant...

MS Hospital Visits Increase in Warmer Weather 
https://www.medscape.com/viewarticle/949387

Apr 14th, 2021 - Individuals with multiple sclerosis (MS) seek additional acute medical care during periods of unusually warm weather, a new study has found, raising concerns about possible increased symptoms and healthcare usage over the long-term because of glob...

see more →

Patient Education  123 results see all →